Köbel Martin, Ronnett Brigitte M, Singh Naveena, Soslow Robert A, Gilks C Blake, McCluggage W Glenn
Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta (M.K.) Department of Pathology, Vancouver General Hospital, Vancouver, British Columbia (C.B.G.), Canada Department of Pathology and Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, Baltimore, Maryland (B.M.R.) Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (R.A.S.) Department of Cellular Pathology, Barts Health NHS Trust, London (N.S.) Department of Pathology, Belfast Health and Social Care Trust, Belfast (W.G.M.), UK.
Int J Gynecol Pathol. 2019 Jan;38 Suppl 1(Iss 1 Suppl 1):S123-S131. doi: 10.1097/PGP.0000000000000488.
P53 immunohistochemistry has evolved into an accurate surrogate reflecting the underlying TP53 mutation status of a tumor, and has utility in the diagnostic workup of endometrial carcinomas. Recent work predominantly carried out in tubo-ovarian high-grade serous carcinoma has revealed 4 main patterns of p53 staining (normal/wild-type, complete absence, overexpression, and cytoplasmic); the latter 3 patterns are variably termed abnormal/aberrant/mutation-type and are strongly predictive of an underlying TP53 mutation. The aim of this review is to provide practical advice to pathologists regarding various aspects of p53 immunohistochemical staining. These include laboratory methods to optimize staining, a description of the different patterns of staining, advice regarding the interpretation, and reporting of p53 staining and practical uses of p53 staining in endometrial carcinoma diagnosis. Illustrations are provided to aid in the interpretational problems.
p53免疫组化已发展成为反映肿瘤潜在TP53突变状态的准确替代指标,在子宫内膜癌的诊断检查中具有实用价值。最近主要在输卵管卵巢高级别浆液性癌中开展的研究揭示了p53染色的4种主要模式(正常/野生型、完全缺失、过表达和细胞质染色);后3种模式被不同地称为异常/畸变/突变型,强烈预示着潜在的TP53突变。本综述的目的是就p53免疫组化染色的各个方面为病理学家提供实用建议。这些建议包括优化染色的实验室方法、不同染色模式的描述、p53染色解读和报告的建议以及p53染色在子宫内膜癌诊断中的实际应用。文中提供了插图以帮助解决解读问题。